or Try an Advanced Search...

    Severe And Rare Diseases Stocks List

    Symbol Grade Name % Change
    RLYB D Rallybio Corporaton -3.65
    LIFE D aTyr Pharma, Inc. -0.59
    ABEO F Abeona Therapeutics Inc. -3.51
    IONS F Ionis Pharmaceuticals, Inc. -1.88
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Rare Diseases Biotechnology Dystrophy Genetics Myopathy Organ Systems Acromegaly Adeno Associated Virus Alcohol Alport Syndrome Amyloid Amyloidosis Anemia Angioedema Antisense RNA Apatorsen Biology Biopharmaceutical Blood Diseases CRISPR

    Related ETFs - A few ETFs which own one or more of the above listed Severe And Rare Diseases stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 4.43
    PBE C PowerShares Dynamic Biotech & Genome 2.67
    HELX D Franklin Genomic Advancements ETF 2.41
    BBP D BioShares Biotechnology Products Fund 1.71
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 1.64
    View all Severe And Rare Diseases ETFs...
    Compare ETFs
    Compare BBP to LABD Compare PBE to BBP Compare PBE to LABD

        Severe And Rare Diseases Stocks Recent News

        Date Stock Title
        May 8 IONS Ionis Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 8 IONS Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
        May 8 IONS Ionis Pharmaceuticals Inc (IONS) Q1 2024 Earnings Call Transcript Highlights: Key Developments ...
        May 7 IONS Ionis Pharmaceuticals, Inc. (IONS) Q1 2024 Earnings Call Transcript
        May 7 IONS Ionis Pharmaceuticals (IONS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
        May 7 IONS Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
        May 7 RLYB Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference
        May 7 ABEO Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
        May 7 IONS Ionis Pharmaceuticals GAAP EPS of -$0.98 beats by $0.09, revenue of $119M misses by $17.41M
        May 7 IONS Ionis reports first quarter 2024 financial results
        May 6 IONS Ionis Pharmaceuticals Q1 2024 Earnings Preview
        May 6 IONS Wall Street's Insights Into Key Metrics Ahead of Ionis Pharmaceuticals (IONS) Q1 Earnings
        May 6 LIFE aTyr Pharma to Present at Upcoming Investor Conferences
        May 3 ABEO Abeona Therapeutics prices its $75M offering; shares rise
        May 3 ABEO Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
        May 2 ABEO Buying The Dip In Abeona Therapeutics After The Recent Manufacturing-Related CRL
        May 2 LIFE aTyr Pharma GAAP EPS of -$0.23 beats by $0.02, revenue of $0.24M beats by $0.22M
        May 2 LIFE aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
        Related Industries: Biotechnology
        Related Stock Lists: Rare Diseases Biotechnology Dystrophy Genetics Myopathy Organ Systems Acromegaly Adeno Associated Virus Alcohol Alport Syndrome Amyloid Amyloidosis Anemia Angioedema Antisense RNA Apatorsen Biology Biopharmaceutical Blood Diseases CRISPR
        Severe And Rare Diseases

        Severe and rare diseases are medical conditions that are very serious, often life-threatening, and affect a small number of people. These diseases are often difficult to diagnose and treat, and may require specialized care. Examples of severe and rare diseases include cystic fibrosis, muscular dystrophy, and Huntington's disease.

        Browse All Tags